XML 34 R13.htm IDEA: XBRL DOCUMENT v2.3.0.15
Financial Instruments
6 Months Ended
Sep. 30, 2011
Financial Instruments [Abstract] 
Financial Instruments

8. FINANCIAL INSTRUMENTS

 

Foreign Currency Contracts

 

The Company enters into forward contracts and foreign currency swap contracts to manage the foreign currency risk associated with monetary accounts and anticipated foreign currency denominated transactions. The Company hedges committed exposures and does not engage in speculative transactions. As of September 30, 2011, the aggregate notional amount of the Company's outstanding foreign currency forward and swap contracts was $3.3 billion as summarized below:

     Foreign Currency Amount         Notional Contract Value in USD
Currency Buy   Sell Buy   Sell
(In thousands)
Cash Flow Hedges            
CNY            1,409,800                          -    $           220,402    $                    -  
EUR                   42,371                     5,777                   57,729                     7,944
HUF            11,353,000                          -                     52,977                          -  
ILS                 185,100                          -                     49,751                          -  
MXN              1,482,700                          -                   109,931                          -  
MYR                 407,350                          -                   128,162                          -  
SGD                   62,035                          -                     47,952                          -  
Other    N/A     N/A                    59,995                     4,870
                          726,899                   12,814
Other Forward/Swap Contracts                
BRL                   35,700                   56,700                   19,434                   30,866
CAD                   44,984                   95,947                   44,945                   96,480
CNY              2,244,777              2,101,848                 347,900                 328,000
EUR                 239,240                 216,210                 327,088                 297,622
GBP                   15,634                   33,832                   24,656                   52,932
HUF              9,136,500              7,489,200                   42,634                   34,947
JPY              6,084,846              2,934,642                   79,355                   38,205
MXN                 892,540                 340,410                   66,175                   25,239
MYR                 164,180                   24,680                   51,655                     7,765
SEK              2,361,373                 725,093                 348,700                 107,671
Other    N/A     N/A                  132,925                   56,637
                       1,485,467              1,076,364
                 
   Total Notional Contract Value in USD            $        2,212,366    $        1,089,178
                 


       Certain of these contracts are designed to economically hedge the Company's exposure to monetary assets and liabilities denominated in a non-functional currency and are not accounted for as hedges under the accounting standards. Accordingly, changes in the fair value of these instruments are recognized in earnings during the period of change as a component of Interest and other expense, net in the Condensed Consolidated Statements of Operations. Gains or losses from fair value adjustments for these instruments are designed to offset losses and gains from the Company's revaluation of monetary assets and liabilities denominated in a non-functional currency. As of September 30, 2011 and March 31, 2011, the Company also has included net deferred gains and losses, respectively, in other comprehensive income, a component of shareholders' equity in the Condensed Consolidated Balance Sheets, relating to changes in fair value of its foreign currency contracts that are accounted for as cash flow hedges. These deferred gains and losses were not material, and the deferred losses as of September 30, 2011 are expected to be recognized as a component of cost of sales over the next twelve-month period. The gains and losses recognized in earnings due to hedge ineffectiveness were not material for all fiscal periods presented and are included as a component of Interest and other expense, net in the Condensed Consolidated Statements of Operations.

 

The following table presents the fair value of the Company's derivative instruments located on the Condensed Consolidated Balance Sheets utilized for foreign currency risk management purposes:

  Fair Values of Derivative Instruments  
  Asset Derivatives   Liability Derivatives
  Balance Sheet Location   Fair Value   Balance Sheet Location   Fair Value
     September 30, 2011  March 31, 2011      September 30, 2011  March 31, 2011
  (In thousands)
Derivatives designated as hedging instruments                  
Foreign currency contracts Other current assets    $        1,491  $      19,579   Other current liabilities    $    (33,953)  $         (778)
                   
Derivatives not designated as hedging instruments                  
Foreign currency contracts Other current assets    $      25,002  $        4,492   Other current liabilities    $    (23,414)  $      (6,122)